Avation Medical vs Idexx Laboratories
Side-by-side comparison of AI visibility scores, market position, and capabilities
Avation Medical makes Vivally, the only FDA-cleared closed-loop wearable neuromodulation device for overactive bladder (OAB); raised $22M to commercialize at-home tibial nerve stimulation.
About
Avation Medical is a neuromodulation and digital health company focused on making wearable peripheral nerve stimulation accessible for patients with chronic conditions. The company''s flagship product, the Vivally System, received FDA 510(k) clearance in April 2023 for treating urinary urgency and urge urinary incontinence (UUI) caused by overactive bladder (OAB) syndrome. Vivally is the only closed-loop, non-invasive neuromodulation device cleared for at-home use for bladder control in the U.S. market.
Veterinary diagnostics leader with $3.81B FY2024 revenue; 130,000+ analyzer installed base; AI-powered inVue Dx digital cytology; VetConnect data platform; pet humanization tailwind.
About
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headquartered. The company trades on Nasdaq (IDXX) and reported $3.81 billion in revenues for FY2024, maintaining its dominant position in point-of-care veterinary diagnostics through an installed base of over 130,000 Catalyst chemistry analyzers, ProCyte hematology systems, and SNAP rapid assay devices deployed in veterinary clinics worldwide. CEO Jay Mazelsky has continued IDEXX's expansion into AI-powered diagnostics and digital pathology, building on over four decades of veterinary-specific product development.
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.